SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Active filters
Keyword
All time
Results for " Injection Site " 1 found 🔀 AI-powered Shuffle
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to